INS and Hyperglycemia: Hence, reduction of blood sugar in T2DM (where there is hyperglycemia) by GLP-1 appears to be secondary to hyperglycemia (which increases insulin secretion and decreases glucagon release) as well as due to a direct action of GLP-1 on glucagon release which is potentiated by hyperglycemia.